Sign in

CIK 0001764013

  • Large accelerated filer

Immunovant, Inc.

Sign in to watch
Ticker
IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
832771572
Phone
+1 917-410-3120
Business address
1000 PARK FORTY PLAZA, DURHAM, NC, 27713
Former names
Health Sciences Acquisitions Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$895,852
in 9 filings, $173K under 10b5-1 plans

Net −$895,852. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-22 Barnett Eva Renee Chief Financial Officer Sale −2,930 $36.15 $106K 320,420
2024-02-22 Levine Mark S. Chief Legal Officer Sale −2,134 $36.15 $77K 301,968
2024-02-22 Macias William L. Chief Medical Officer Sale −2,221 $36.15 $80K 330,952
2024-02-22 Butchko Julia G. Chief Development Officer Sale −2,146 $36.15 $78K 407,817
2024-02-22 Salzmann Peter Chief Executive Officer Sale −13,454 $36.15 $486K 931,231
2024-01-26 Levine Mark S. Chief Legal Officer Sale −2,981 $37.91 $113K 304,148
2024-01-26 Levine Mark S. Chief Legal Officer Sale −46 $38.45 $2K 304,102
2024-01-26 Geffner Michael Chief Medical Officer Sale −9,948 $37.91 $377K 90,052
2024-01-26 Geffner Michael Chief Medical Officer Sale −153 $38.45 $6K 89,899
2024-01-18 Macias William L. Chief Medical Officer Sale −424 $41.03 $17K 333,173
2024-01-11 Barnett Eva Renee Chief Financial Officer Sale −2,681 $41.64 $112K 324,184
2024-01-11 Barnett Eva Renee Chief Financial Officer Sale −834 $42.43 $35K 323,350
2024-01-05 Butchko Julia G. Chief Development Officer Sale −1,297 $38.59 $50K 409,963
2024-01-05 Salzmann Peter Chief Executive Officer Sale −3,824 $38.59 $148K 944,685
2023-12-01 Fromkin Andrew J. Director Sale 10b5-1 −3,941 $38.78 $153K 97,067
2023-12-01 Fromkin Andrew J. Director Sale 10b5-1 −3,636 $39.81 $145K 93,431
2023-12-01 Fromkin Andrew J. Director Sale 10b5-1 −4,773 $40.46 $193K 88,658
2023-12-01 Pande Atul Director Sale 10b5-1 −4,129 $38.80 $160K 91,379
2023-12-01 Pande Atul Director Sale 10b5-1 −3,374 $39.82 $134K 88,005
2023-12-01 Pande Atul Director Sale 10b5-1 −4,847 $40.46 $196K 83,158

Page 15 of 18 · 351 trades